Chairman
Opko Health, Inc. (OPK)Equibles does not estimate personal net worth.
Get an email with a short summary when Opko Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get OPK alertsDr. Elias Zerhouni is recorded as Chairman at Opko Health, Inc. (OPK). Dr. Elias Zerhouni has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Opko Health, Inc. on November 4, 2026. Opko Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Opko Health, Inc. includes Phillip Frost (CEO), Elias Zerhouni, M.D. (Chairman), OPKO Health (Chairman) and 7 others.
“I'll begin with MODEX, where our work during the third quarter centered on clinical execution and preparation for the next stages of development. We continue to advance multiple programs while building the foundation for the next wave of opportunities across our portfolio.”
“And thank you, everyone, for joining us today. And thank you, Phil. Let me take this opportunity to highlight continued advancements in our pipeline, targeting important unmet clinical needs across large markets.”
“Thank you, Dr. Frost, and good morning, everyone, and thank you for joining us at this meeting. Let me take this opportunity to highlight our pipeline development as we progress programs targeting important unmet clinical needs across large markets.”
“Well, thank you, Phil, and good afternoon, everyone. Let me start with the biopharma side of our business because that's where we're making tremendous progress, advancing our pipeline right now.”
“Well, thank you, Phil, and thank you all for joining today. Let me start with the Diagnostics segment where our restructuring efforts are continuing. First, as mentioned by Phil, we signed a definitive agreement with Labcorp to sell the oncology and related clinical testing assets of BioReference Health.”
Diagnostics & Research · Healthcare
Chairman
